Medicine containing inhibitors of the progesterone synthesis of the trilostane or epostane type and antigestagens

Elger Walter Dr., Beier Sybille Dr., KOSUB BEATE, Fähnrich Marianne, Chwalisz Krzysztof Dr., Hasan Syed Hamiduddin Dr., Potts Gordon Oliver Dr.
1988
OA: closed Metadata only
⚙ AI-generated summary by qwen3.7-flash, 2026-09-20 ⓘ

This patent describes a medicine combining trilostane or epostane with antigestagens for inducing labour, terminating pregnancy, and treating hormone-dependent tumors, endometriosis, and dysmenorrhoea.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

The medicine contains a progesterone synthesis inhibitor (ProH) of the trilostane or epostane type and an antigestagen (AG) and is used for inducing labour at term in humans and animals and for terminating normal or pathological pregnancy. The combination according to the invention is also suitable for treating hormone-dependent tumours, endometriosis and dysmenorrhoea.

My notes (saved in your browser only)

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-07-12T06:14:43.533933+00:00